Table 6. Costs, RIG administrations and ICER as a result of a 1.5-fold increased rabies vaccination uptake for diverse risk groups, the Netherlands, 2018 .
Risk group | Travellers < 35 years | Travellers to south-eastern and western Asia | Men | Travellers to South America | Travellers having at least one risk factor | Travellers having all risk factors togethera |
---|---|---|---|---|---|---|
Additional vaccinated persons | 11,970 | 9,800 | 8,570 | 1,800 | 17,290 | 3,410 |
95% UI | 2,850–22,100 | 1,880–18,530 | 1,280–16,540 | −3,280–6,730b | 51,60–31,160 | −1,750–8,810b |
Avoided number of RIG administrations | 45 | 41 | 29 | 4 | 60 | 16 |
Additional costs | 1,206,000 | 966,400 | 867,100 | 188,900 | 1,755,100 | 333,100 |
95% UI | 226,000–2,413,900 | 421,000–2,290,000 | 77.400–1,819,800 | −391,900–765,300b | 482,700–3,341,000 | −260,600–941,800b |
ICER: Incremental costs per additional vaccinated person | 101 | 99 | 101 | 105 | 102 | 98 |
95% UI | 82–116 | 71–116 | 0.75–118.0 | 71–151 | 88–116 | 26–181 |
ICER: Incremental costs per avoided RIG administration | 26,970 | 23,760 | 30,370 | 46,750 | 29,220 | 21,320 |
95% UI | 9,530–52,460 | 5,790–49,510 | 5,323–64,110 | −129,950–229,830b | 14,250–53,000 | −24,010–70,190b |
ICER: incremental cost-effectiveness ratio; RIG: rabies immunoglobulin; UI: uncertainty interval.
a This group consist of men younger than 35 years travelling to south-eastern and western Asia.
b Owing to low numbers in this specific risk group, the UI are not interpretable.
The table presents averages with 95% UI. Note that in Table 4 total costs per vaccinated persons are presented, whereas in Table 5 the incremental costs per additional vaccinated person are presented, and they are therefore not comparable. For full details see Supplementary Table S3.